TAB1 Antibodies

Santa Cruz Biotechnology offers a broad range of TAB1 monoclonal antibodies for research focused on understanding TAB1 protein functions. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAB1, or TGF-beta-activated kinase 1-binding protein 1, plays a crucial role in cellular signaling pathways, particularly in the regulation of inflammation and cell survival. By modulating the activity of TAK1, TAB1 is essential for mediating responses to stress and cytokines, making it a significant player in various physiological and pathological processes. Understanding TAB1's function can provide insights into diseases such as cancer and autoimmune disorders. TAB1 monoclonal antibodies enable precise detection and analysis of TAB1 expression patterns across different cell types and tissues. Researchers can utilize TAB1 monoclonal antibodies to investigate protein-protein interactions and signaling cascades involving TAB1. Advanced research techniques incorporating TAB1 monoclonal antibodies help reveal new therapeutic targets and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular signaling mechanisms and disease pathways.